News / Press Releases - January 20, 2026
Brussels, 20 January 2026 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges today’s adoption of the Critical Medicines Act (CMA) by the European Parliament, which upholds the approach set out in the Public Health Committee (SANT) report endorsed in December 2025. EUCOPE reiterates the… read more
News / Press Releases - January 19, 2026
Findings to be discussed in EUCOPE webinar on 4 February 2026 Brussels, January 2026 – A new study quantifying the economic footprint of the small to mid-sized biopharmaceutical industry as represented by EUCOPE shows that EUCOPE member companies make a substantial contribution to the EU27… read more
Press Releases - December 17, 2025
Brussels, 17 December 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) recognises the publication of the European Biotech Act Part I, as a promising initiative. This Act acknowledges biotechnology and biomanufacturing as strategic pillars for the EU’s competitiveness, health resilience and scientific leadership. EUCOPE… read more
Press Releases - December 16, 2025
On 15 December 2025, the European Parliament Public Health Committee (SANT) adopted its report on the Critical Medicines Act (CMA). The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) deems that the adopted text marks a troubling shift away from the CMA’s original purpose: addressing shortages of… read more
Press Releases - December 11, 2025
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the provisional political agreement reached on the EU General Pharmaceutical Legislation (GPL) and recognises the efforts of the EU Institutions to modernise the pharmaceutical framework for the first time in over 20 years. This revision will have… read more
News / Press Releases - December 2, 2025
On 2 December 2025, EU Ministers of Health in the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) formally adopted its General Approach on the Critical Medicines Act (CMA). EUCOPE appreciates the clear distinction between measures applying to critical medicines and to medicinal products… read more
EUCOPE Resources / Press Releases - November 17, 2025
Press Release Brussels, 17 November 2025 Today, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) published a new report titled Competitiveness of the EU Life Sciences Sector – Analysis of the impact of current and future EU legislations on the competitiveness of the EU life sciences… read more
News / Press Releases - July 9, 2025
Brussels, 9 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) reckons both the EU Medical Countermeasures and Stockpiling Strategies, published today, as positive steps toward improving the EU’s preparedness for future health emergencies. In an increasingly uncertain geopolitical scenario, strengthening the EU medical… read more
News / Press Releases - July 2, 2025
Brussels, 2 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) appreciates and supports the European Commission’s ambition to strengthen the EU’s healthcare ecosystem through a comprehensive EU Life Sciences Strategy. A more integrated and innovation-friendly regulatory framework is essential for the EU to… read more
News / Press Releases - June 5, 2025
Brussels, 5 June 2025 – Following the negotiators in the Council having agreed their General Approach yesterday (4 June), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the step forward in the legislative process and urges EU policymakers to safeguard the EU’s innovation-driven life sciences… read more
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information